Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Boston Scientific Corporation
Boston Scientific Corporation
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
University of California, San Francisco
NiKang Therapeutics, Inc.
Shanghai Zhongshan Hospital
Arsenal Biosciences, Inc.
University of Pittsburgh
Hoffmann-La Roche
Revolution Medicines, Inc.
German Cancer Research Center
Stanford University
Hospital Universitario 12 de Octubre
Tampere University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Atara Biotherapeutics
Imunon
The First Affiliated Hospital with Nanjing Medical University
Advaxis, Inc.
Catalysis SL
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sheba Medical Center
Becton, Dickinson and Company
Qingdao Central Hospital
Sesen Bio, Inc.
Genelux Corporation
Revolution Medicines, Inc.
Catalysis SL
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Guangxi Medical University
Jiangsu Cancer Institute & Hospital
Jiangsu Cancer Institute & Hospital
Belgian Gynaecological Oncology Group
Cedars-Sinai Medical Center
Neovii Biotech
Royal Marsden NHS Foundation Trust
South Tyneside and Sunderland NHS Foundation Trust
DNAtrix, Inc.
Yale University
Dendreon
Merck Sharp & Dohme LLC
UroGen Pharma Ltd.
Assistance Publique - HĂ´pitaux de Paris
AVEO Pharmaceuticals, Inc.